Drug-Resistant Tuberculosis Types and Their Treatment Regimens Using First-Line, Second-Line Injectable, Third-Line, Fluoroquinolones, Aminoglycosides, Cyclic Polypeptides, Novel and Repurposed Anti-Tuberculosis Drugs

JOURNAL ARTICLE published September 2022 in Journal of Biomedical Research & Environmental Sciences

Authors: David Kajoba Mumena | Geoffrey Kwenda | Caroline Wangari Ngugi | Andrew Kimanga Nyerere